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ABSTRACT
The virulence gene icsA of Shigella flexneri encodes
an invasion protein crucial for host colonization by
pathogenic bacteria. Within the intergenic region
virA-icsA, we have discovered a new gene that
encodes a non-translated antisense RNA (named
RnaG), transcribed in cis on the complementary
strand of icsA. In vitro transcription assays show
that RnaG promotes premature termination of tran-
scription of icsA mRNA. Transcriptional inhibition is
also observed in vivo by monitoring the expression
profile in Shigella by real-time polymerase chain
reaction and when RnaG is provided in trans.
Chemical and enzymatic probing of the leader
region of icsA mRNA either free or bound to RnaG
indicate that upon hetero-duplex formation an
intrinsic terminator, leading to transcription block,
is generated on the nascent icsA mRNA. Mutations
in the hairpin structure of the proposed terminator
impair the RnaG mediated-regulation of icsA tran-
scription. This study represents the first evidence
of transcriptional attenuation mechanism caused
by a small RNA in Gram-negative bacteria. We also
present data on the secondary structure of the
antisense region of RnaG. In addition, alternatively
silencing icsA and RnaG promoters, we find that
transcription from the strong RnaG promoter
reduces the activity of the weak convergent icsA
promoter through the transcriptional interference
regulation.
INTRODUCTION
Until recently, bacterial gene expression was believed to be
regulated essentially by repressor or activator proteins
acting mainly at the level of transcription initiation. At
present,  140 bacterial small (50–500nt) regulatory
RNAs, that do not encode proteins (ncRNAs), have
been identiﬁed by means of systematic computer
analysis, microarrays and cloning-based screening (1).
Recently, a database collecting the small RNA (sRNA)
genes has become available (2). sRNAs have been
characterized not only in bacteria but also in phages,
plasmids and in eukaryotic cells (microRNAs and
interfering RNAs), suggesting that this level of regulation
is widespread among living organisms (3). Although the
function of many sRNAs remains to be elucidated, current
studies indicate that they act by three general mechanisms.
Few sRNAs are integral parts of the RNA–protein
complexes as the 4.5S RNA component of the signal rec-
ognition particle and the RNase P RNA. A second class of
regulatory sRNAs is represented by the so-called ‘molec-
ular decoys’, which mimic the structure of other nucleic
acids. Their target is usually a protein rather than another
RNA (examples are the 6S RNA and the CsrB/CsrC
RNAs). The non-coding RNAs of the third class are the
best known and act by basepairing (RNA as antisense)
with a second RNA, usually a messenger RNA, to
change its behavior. Regulatory sRNAs can be encoded
either in cis by the opposite strand of the target mRNA or
by a free-standing gene located far from the target gene.
Diﬀerent RNA–RNA mediated mechanisms, entailing
changes in processing and degradation of the target
message and alterations in the eﬃciency of transcription
and translation, have been described (3–7). It is becoming
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in general, can also play a key role in controlling the
expression of virulence genes or can aﬀect adaptive
stress-responses, which are important for bacteria to
survive into the host. Indeed, recent studies have identiﬁed
sRNAs in human pathogens as Listeria monocytogenes
(8,9), Staphylococcus aureus (10), Pseudomonas aeruginosa
(11), Salmonella (12–14) and Vibrio cholerae (15–18).
Interestingly, in Escherichia coli, the majority of sRNAs
are present in pathogenic strains, suggesting that they
might control virulence.
Shigella ﬂexneri is a Gram-negative pathogenic bacte-
rium that causes human bacillary dysentery. The icsA gene
(named also virG) of Shigella, located on the 230-kb vir-
ulence plasmid pINV, (19), encodes a protein required for
the invasion of intestine epithelial cells and intercellular
spread of pathogens (20). IcsA, one of the biggest proteins
(1102 amino acid residues) in bacteria, is an outer
membrane protein, which induces host actin polymeriza-
tion at one pole of the cell, resulting in actin-tail formation
which propels the bacterium from one cell to another (21).
As most plasmid virulence genes, the expression of icsA is
modulated by temperature and repressed by the nucleoid
protein H-NS (22–26). In contrast to other genes of the
invasivity regulon, icsA is not submitted to the VirF–VirB
regulatory cascade but seems to be activated only by the
AraC-like transcriptional eﬀector VirF (27,28).
In this study, we have identiﬁed and characterized the
ﬁrst regulatory RNA encoded by the virulence plasmid of
S. ﬂexneri. This small RNA (named RnaG), acting as
antisense, is 450nt long and is transcribed from the com-
plementary strand of the target icsA mRNA. We show
that two mechanisms contribute to the RnaG-mediated
regulation of icsA: (i) icsA and RnaG promoters, sponsor-
ing convergent transcription, are subjected to
transcriptional interference (TI) regulation deﬁned as the
direct negative impact of a transcriptional process on a
second transcriptional process in cis (29); and (ii) RnaG
is capable to interact with the icsA mRNA and to cause
premature termination of transcription of the target gene
possibly by a transcriptional attenuation mechanism.
Chemical and enzymatic RNA probing experiments
show that the RNA–RNA interaction induces a change
of the secondary structure of the leader region of the icsA
transcript, promoting the formation of an alternative
spatial conformation resembling a Rho-independent ter-
minator. Mutations, which destabilize the conserved stem
structure of this intrinsic terminator, signiﬁcantly aﬀect
the ability of the RnaG to inhibit icsA transcription
in vitro. The secondary structure of the antisense region
( 120nt) of RnaG was also determined by chemical
probing. To our knowledge, this is the ﬁrst strong
evidence of such a mechanism in a human life-threatening
bacterial pathogen.
MATERIALS AND METHODS
Bacterial strains and general procedures
Bacterial strains used in this work were Shigella
ﬂexneri M90T (20) and E. coli K-12 DH10b [mcrA
(mrr-hsdRMS-mcrBC) lacX74 deoR recA1] (30),
P90C [ara D(lac-pro) thi] (31) and HMG11 [araD139,
D(ara, leu)7697, D(lacZ) M15, galU, galK, strA] (32).
DNA isolation, agarose gel electrophoresis, polymerase
chain reaction (PCR), restriction digestions, cloning and
other DNA manipulation methods were performed
according to standard procedures (30). Plasmid
pKK232-8 was from Pharmacia. Beta-galactosidase
assays were performed as described by Miller (33) on
sodium dodecyl sulfate (SDS)–chloroform-permeabilized
cells grown in LB broth (pH 7). Antibiotics and chemicals
were used at the following concentrations: ampicillin
50mg/ml; cloramphenicol 25mg/ml; trimethoprim 10mg/
ml; Xgal 20mg/ml. Radioactivity associated with DNA
or RNA was detected and quantiﬁed by Molecular
Imager (Bio-Rad, model FX). Oligonucleotides used in
this study are listed in Table 1.
DNA manipulations
pGT1127 has been constructed by cloning into
pGEMT-Easy a 866-bp fragment obtained upon PCR
ampliﬁcation with oligo pair AH16 and GZ25 using as
template pMYSH6601, a pBR322-derived vector contain-
ing the virA-icsA genetic region (4.472kb) of the
S. ﬂexneri 2a virulence plasmid pMYSH6000 (34). In
order to study the intrinsic activity of PicsA and PRnaG
promoters without the eﬀect induced by the convergent
promoter activity, we inactivated either PRnaG or PicsA,
thus giving rise to PicsA/RnaGmut and PicsAmut/RnaG. The
PicsA/RnaGmut (silenced RnaG promoter) was obtained by
Table 1. Desoxyoligonucleotides used in this study
Name Sequence
AH16 50-GTCGAATTCCATGATGAGTC-30
GZ25 50-GTTATATACCACGGATCCATTC-30
RM10 50-CATGCACTGTGTTATCAGTAAG-30
FM10 50-CTTACTGATAACACAGTGCAT-30
GRNdeI 50-GAACATATGCTGTGCTTGCTTTGA-30
GFNdeI 50-CAGCATATGTTCTCCCGTTGCATTG-30
GZ24 50-GCAGATCTTGCATTGGAGAGTC-30
G+120H 50-CCCAAGCTTGTGGTTGATAAACCCC-30
G-383E 50-CGGAATTCTCCTGATGTATTTTCC-30
G+1H 50-CCCAAGCTTGTTGCATTGATATATAACAC-30
G+370E 50-GAGGAATTCCATCAACAGGTGTTAATAA-30
AC8 50-TAGATTTCGGCAAGCGTACAG-30
G-112 50-TTCTTTCTGTACGCTTGC-30
G-14E 50-GGTGAATTCCTCCCG TTGCATTGATATA-30
G-220 50-CACAACTTTCCTACCAGACTCTCC-30
G+187 50-CCTGTGAACATTGGGTCAT-30
G+59 50-TTTGCATATATCGTCCCTTTATTCCG-30
G+50 50-GGTTGAGGCTTTGTTTAATATG-30
G+110 50-TTGATAAACCCCTGAAAAGA-30
G-100 50-GAAAGAACTGAAAAGTTGCGG-30
ACC9 50-CCTTTACCGTAGGTAATTCTC-30
G-290 50-ATTCTTCTCTTTAAGAAAACGATAC-30
naF 50-TGAAGCCGCACGTTATGAAG-30
naR 50-TCAACGTAATCGCCCAGGTT-30
iaF 50-TGATGGACTTTCTCCCTTGGG-30
iaR 50-TACCACGCATCCATTCCATCT-30
rgF 50-GCTTTCCCCCTCTTTTTTTCA-30
rgR 50-CAACGGGAGAAATTTACCTGTGTC-30
G501 50-ATATCGTCCCTTTATATGTGATAAAACGGAATCT-30
G502 50-AGATTCCGTTTTATCACATATAAAGGGACGATAT-30
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virA regulatory region of pMYSH6601 as template. Oligos
AH16 and RM10 were used as primers in the ﬁrst reaction
round (PCR-1), while oligos FM10 and GZ25 served as
primers in PCR-2. Equimolar amounts of fragments from
PCR-1 and PCR-2 were used as templates in PCR-3,
primed by the oligos pair AH16 and GZ25. The 866-bp
fragment thus obtained was cloned into pGEMT-Easy,
giving rise to pGT1129. Sequencing conﬁrmed the
presence of PRnaG modiﬁed in the –10 region (50-TGTG
TT-30) (Figure 1B).
The PicsAmut/RnaG (silenced icsA promoter) was obtained
by introducing a NdeI restriction site into the –10 consen-
sus box. To this end, the two amplicons obtained from the
icsA-virA region of pMYSH6601 with the oligos pairs
AH16 and GRNdeI or GFNdeI and GZ25 were
digested with NdeI and ligated to each other. The resulting
866-bp fragment was cloned into pGEMT-Easy to obtain
pGT1083; sequence analysis conﬁrmed the presence of a
modiﬁed –10 region (50-CATATG-30) into the PicsA
promoter (Figure 1B).
Plasmid pKG673 has been constructed by cloning into
the BamHI site of pKK232-8 a 673-bp DNA fragment
(from positions –262 to +419) ampliﬁed by PCR using
the primer pair GZ24 and GZ25 and pMYSH6601 DNA
as template.
Plasmids pTZRnaG, pTZRnaG120 and pTZicsA370
were obtained by cloning, into the HindIII/EcoRI restric-
tion sites of pTZ19R, under the control of the T7
promoter, the RnaG gene (from positions –383 and –14
to +120) and the leader region of icsA (from positions +1
to +370), respectively. These DNA fragments were
obtained by PCR using pMYSH6601 as DNA template
and the following primer pairs G+120H/G-383E,
G+120H/G-14E and G+1H/G+370E. EcoRI linearized
plasmids, pTZRnaG, pTZRnaG120 and pTZicsA370
were used as templates in in vitro transcription reactions
with T7 RNA polymerase as described by Brandi et al.
(35) to synthesize RnaG, RnaG120 and icsA transcripts.
Substitution of four bases on icsA sequence (from posi-
tions +81 to +84), to produce the icsA81/4 mutant, was
carried out by the QuikChange Site-Directed Mutagenesis
Kit (Stratagene) using pGT1129 DNA as template and the
mutagenic oligos G501 and G502. The resulting plasmid
pGT1129M was used in in vitro transcription assay. The
mutation was conﬁrmed by DNA sequencing.
Construction of transcriptional fusions
Plasmids carrying fusions with the lacZ reporter gene were
constructed by cloning diﬀerent PCR-generated fragments
into the multicloning site of the lacZYA transcriptional
fusion vector pRS415 (33). Plasmid pULS1127, containing
the PicsA–lacZ fusion, was obtained by cloning a 866-bp
EcoRI–BamHI fragment generated using AH16 and
GZ25 as forward and reverse primers and pMYSH6601
as template. Plasmid pULS1287, containing the PRnaG–
lacZ fusion, was generated by cloning a 580-bp
BamHI-BglII fragment obtained using GZ25 and AC8
as forward and reverse primers, respectively, and
pMYSH6601 as template. Plasmid pULS1129, carrying
the PicsA/RnaGmut-lacZ fusion, and plasmid pULS1288,
carrying the PicsAmut/RnaG-lacZ fusion, were obtained
with the oligo pairs used for the construction of the
corresponding wt fusions but using plasmids
pGT1129 and, respectively, pGT1083 as templates. The
aforementioned lacZ fusions were then transferred by
homologous recombination to the lac transducing
phage RS45, and then integrated (31) into the chromo-
some of E. coli P90C at the  attachment site, thus
generating strains ULS1127, ULS1129, ULS1287 and
UL1288 (Figure 2B). Monolysogens were selected by
means of a PCR test using primers corresponding to
sequences ﬂanking the bacterial and prophage attachment
sites (36).
Primer extension analysis
After an initial denaturation of RNA samples at 80 C for
5min, primer extension analysis was carried out at 42 C
for 45min in reaction mixtures (10ml) containing the
supplied buﬀer, 0.1mM dNTP mix, 3U of AMV reverse
transcriptase (Roche) and 3 pmol of [g
 32P]-oligo
as primer. The reaction products were analyzed on 7%
PAGE-urea gel in parallel with the dideoxy chain
termination sequencing reaction using the same
primer (30).
Mapping the 30-end of the RnaG
Poly(A) tails were added to the 30-termini of RNA using
the E. coli enzyme poly(A) polymerase (GE Healthcare).
The reaction (50ml) was carried out at 37 C for 45min in
40mM Tris–HCl pH 7.7, 10mM MgCl2, 250mM NaCl,
1mM DTT, 50mg/ml BSA, 2.5mM MnCl2, 250mM ATP,
5U of poly(A) polymerase and 15mg of total RNA
extracted from E. coli strain HMG9/pMYSH6601. The
reaction was stopped at 75 C for 10 min in the presence
of EDTA (f.c. 20mM), RNA was precipitated and then
dissolved in 15ml of water. Aliquots of poly(A)-tailed
RNA were used to synthesize a cDNA copy. RNA was
denaturated at 65 C for 5min and subsequently the
reaction (10ml) was carried out at 42 C for 45min in
50mM Tris–HCl pH 8.5, 8mM MgCl2, 30mM KCl,
1mM DTT, 150mM dNTPs, 60pmol anchored
oligo(dT19N)20 and 15U of AMV reverse transcriptase
(Roche). The resulting cDNAs were used as templates in
PCR reaction performed with 130pmol of the anchored
oligo(dT14VN) and 30pmol of the icsA speciﬁc oligo
G-112 as primers. The amplicon obtained after 40 PCR
cycles was subjected to sequencing using the oligo G-220
as primer.
In vitro transcription assay
In vitro transcription from supercoiled pGT1127,
pGT1129 and pGT1083 as DNA templates was carried
out at the indicated temperature for 45min. Each
reaction mixture (40ml) contained 40mM Tris–HCl, pH
7.5, 150mM KCl, 10mM MgCl2, 10mM dithiothreitol,
0.01% Triton X-100, 0.5mM each of NTPs, 2U of
ribonuclease inhibitor and 0.2U of E. coli RNA
polymerase (USB). The reaction was stopped on ice and
RNA was precipitated with ethanol in the presence of 1-mg
3364 Nucleic Acids Research, 2010,Vol.38, No. 10tRNA as carrier. Concerning transcription assays shown
in Figure 7, RnaG was added to the mixture before RNA
polymerase (samples B) or at the step of RNA precipita-
tion (samples E). This protocol ensures that the same
amount of RnaG is present in the couple B/E during
the following elongation step by the reverse transcriptase.
The transcripts were subjected to primer extension as
described above. Alternatively, in vitro transcription was
performed incorporating [a
 32P]-UTP in the de novo
synthesized RNA. DNA template (10–20ng) were
transcribed in a volume of 15ml in the same conditions
indicated above in the presence of 200mM CTP, 10mM
UTP, 1mM ATP, 200mM GTP and 0.2mCi/ml[ a
 32P]-
UTP (3000Ci/mmol). After an incubation of 30min at
37 C, the reaction was stopped by adding an equal
volume of a solution containing 50% formamide and
10mM EDTA and heated at 90 C for 2min.
Chemical and enzymatic RNA probing
Chemical modiﬁcation of RNA was performed as
described previously (37) using the single-strand speciﬁc
reagents DMS (A and C speciﬁc) and CMCT (U and G
speciﬁc).The RNA was incubated for 5min in 20mlo f
buﬀer A (50mM Na-cacodylate, pH 7.5, 5mM MgCl2,
100mM KCl) or 20min in 20ml of buﬀer B (50mM
Na-borate, pH 8, 10mM MgCl2, 50mM KCl) at 32 C
in the presence of the indicated concentrations of DMS
or CMCT, respectively. Control samples were treated
identically with the exception that no modifying reagents
were added. The modiﬁed RNA was subjected to primer
extension as described above.
To perform enzymatic probing, puriﬁed icsA370
mRNA was dephosphorylated using calf intestinal
alkaline phosphatase (Amersham) and labeled with T4
polynucleotide kinase (USB) and [g-
32P]-ATP (30).The
50-end-labeled RNA was additionally extracted from gel
(PAGE). After denaturation at 90 C for 1min and
renaturation for 10min at 32 C, RNA was treated with
RNases T1 or T2 (5min) at the indicated concentrations
in 10ml buﬀer A (20mM HEPES–KOH, pH 7.5, 10mM
MgCl2, 50mM KCl) in the presence of 1mg of carrier
tRNA. The reaction products were analyzed on
10% PAGE-urea gel in parallel with T1 and OH–
ladders (38).
Real-time quantitative PCR
Total RNA was extracted as described by Von Gabain
et al. (39) and cDNA synthesis was performed using the
High Capacity cDNA Reverse Transcription Kit from
Applied Biosystems. The 20-ml reaction mix contained
20mg total RNA from Shigella M90T. Real-time quanti-
tative PCR was performed on a 7300 Real-Time PCR
System (Applied Biosystems) in a 30-ml reaction mix con-
taining 5ml cDNA and Power SYBRGreen PCR Master
Mix (Applied Biosystems). At least three wells were
run for each sample. The relative amounts of icsA and
RnaG transcripts were analyzed using the 2
–
Ct method (40) and the results were indicated as an n-
fold increase relative to the starting sample, which was
chosen as reference. Primers for the nusA transcript, used
as endogenous control, and for the above-mentioned tran-
scripts were designed with the aid of the Primer
Express software v2.0 (Applied Biosystems) and experi-
mentally validated for suitability to the 2
–Ct method.
The following oligos were used: naF and naR for the
nusA transcript; iaF and iaR for icsA; rgF and rgR for
RnaG.
RESULTS
Identiﬁcation and molecular characterization of the RnaG
While cloning diﬀerent DNA fragments carrying the
promoter and part of the coding region of icsA gene of
S. ﬂexneri into the vector pKK232-8, we observed that the
expression of the promoter-less reporter gene cat was
detected independently of the correct orientation of the
icsA promoter (PicsA). This suggested the existence of at
least two convergent promoters, transcribed on diﬀerent
DNA strands, within the icsA DNA sequence. In agree-
ment with this ﬁnding, primer extension analysis reveals
the presence of a promoter, named PRnaG, with reverse
orientation relative to icsA (Figure 1A). Transcripts
originated with two guanines at position +120 and,
albeit to a much lesser extent, at position +118 with
respect to the transcriptional start site of icsA (+1)
previously identiﬁed by Lett et al. (34). The consensus
hexamers –10 and –35 and the transcriptional start sites
of PicsA and PRnaG are shown in Figure 1B. In addition, we
prepared a set of diﬀerent constructs in which the pro-
moters of icsA and RnaG were alternatively inactivated
by introducing mutations in the corresponding –10
elements to produce plasmids pGT1127, pGT1129 and
pGT1083, schematically shown in Figure 1C. Promoter
functioning was tested by primer extension analysis,
carried out on total RNA extracted from E. coli cells
transformed with the pGT plasmids. As expected,
Figure 1D reveals that base exchanges at PRnaG and
PicsA dramatically impair RnaG and icsA promoter
activity, respectively. It is remarkable that the level of
icsA mRNA is signiﬁcantly higher when the RnaG
promoter is inactivated (pGT1129) than in the wt condi-
tion (pGT1127). Moreover, transcription of icsA is
increased at 37 as compared to 30 C. Although in silico
analysis of the DNA sequence indicates the existence of a
short open reading frame (31 amino acid residues) in the
virA-icsA intergenic region, no b-galactosidase activity
could be detected from translational fusions of this
DNA region with the reporter gene lacZ (data not
shown). Altogether, these observations strongly suggest
the presence of a non-coding antisense RNA (RnaG)
encoded in cis on the opposite strand of icsA and comple-
mentary to the ﬁrst 120nt of the mRNA.
The full length of RnaG has been determined by
mapping the 30 end of the transcript. Since bacteria do
not usually show poly(A)+ RNA, a tail of adenines was
incorporated in vitro to the 30 end of total RNA using the
poly(A) polymerase. Subsequently, a cDNA copy was
made using the anchored oligo(dT19N) as primer. The
DNA was then subjected to PCR ampliﬁcation combining
the anchored oligo(dT14VN) and a speciﬁc one designed
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sequenced (Supplementary Figure S1AB). The nucleotide
sequence indicates that transcription possibly terminates
between cytosine at position –332 and adenine at position
–334 so that RnaG would be  450nt long. Because of the
presence of two As at the 30-end of the transcript, that are
not distinguishable from those incorporated during the
poly(A) tail synthesis, we could not identify the transcrip-
tion termination site with single base accuracy. Northern
blot analysis conﬁrms the estimated size of RnaG
(Supplementary Figure S1C). In agreement with the exper-
imental results, computer prediction of secondary struc-
ture of the 30-end of RnaG shows that it might form two
hairpin loops characteristic of ‘Tandem/U shaped’ intrin-
sic terminators (41) (Supplementary Figure S1D). It is
important to notice that the same transcriptional termina-
tion site was also found when RnaG was transcribed
in vitro, using the wt plasmid pGT1127 as template (data
not shown), suggesting that no other factors contribute to
RNA polymerase pausing and leading to termination of
transcription.
The icsA and RnaG promoters are subjected to TI
regulation
The icsA and RnaG promoters are convergent and 120 bp
apart. This arrangement can possibly give rise to TI,
which refers to a direct negative inﬂuence of one
transcriptional process on a second transcriptional
process occurring in cis. Usually the strong promoter
(aggressive) reduces the activity of the weaker convergent
promoter (sensitive) (29). To assess whether TI plays a
role in the regulation of icsA and eventually to establish
which promoter is the sensitive or the aggressive one, we
used plasmids pGT1127, pGT1129 and pGT1083
(Figure 1C). These constructs were transcribed in vitro
and the icsA and RnaG transcripts were detected by
primer extension. As shown in Figure 2A, when the wt
construct pGT1127 is used as template only the RnaG
transcript is visible and no transcription originates from
PicsA. The icsA mRNA becomes evident when pGT1129,
lacking an active PRnaG, is provided as template. This
observation suggests that transcription from the strong
Figure 1. Identiﬁcation of the RnaG promoter. (A) Primer extension analysis was carried out using the oligo G+59 on 10mg of total RNA from the
E. coli wt strain HMG11, a MC1029 derivative, transformed with plasmid pMYSH6601 (lane 2) or pKG673 (lane 3). Lane 1 is the control sample in
the absence of RNA. Lanes G, A, T and C represent the dideoxy sequencing reactions carried out with the same primer. The positions of the two
transcriptional start sites are indicated. Smears below the speciﬁc signals are due to the low quality of some commercial oligonucleotides. (B) The
relevant nucleotide sequence of the regulatory region of the icsA gene. The ﬁrst nine coding triplets of icsA, the transcriptional start point, the –10
and –35 consensus sequences of the icsA and RnaG promoters are indicated. Mutated TATA boxes created in PicsA and PRnaG to construct plasmids
pGT1083 and pGT1129, respectively, are reported above and below the sequence. (C) Schematic representation of plasmids pGT1127 (PicsA/RnaG),
pGT1129 (PicsA/RnaGmut), pGT1083 (PicsAmut/RnaG). (D) Primer extension analysis was performed on 15mg of total RNA from the E. coli strain
HMG11 transformed with plasmids pGT1127, pGT1129 or pGT1083 using a mixture of primers G+110 and G+50 to detect icsA mRNA and
RnaG, respectively. Lanes G, A, T and C represent the sequencing reactions using the primer G+110.
3366 Nucleic Acids Research, 2010,Vol.38, No. 10RnaG promoter (aggressive) dramatically inhibits tran-
scription from the weaker icsA promoter (sensitive). The
interference, calculated as ratio of RnaG (pGT1083) and
icsA (pGT1129) promoter activity, is  12-fold. Moreover,
TI is reciprocal since also transcription of PicsA negatively
aﬀects, albeit at low extent, that of the PRnaG. In fact, the
level of the RnaG transcript is  1.5-fold higher in
pGT1083 carrying an impaired icsA promoter, than in
the wt construct pGT1127.
TI between the PicsA and PRnaG has been further
analyzed in vivo by constructing a series of transcriptional
fusions carrying the lacZ reporter gene under the control
of either icsA and RnaG promoters (Figure 2B). PicsA and
PRnaG transcription was assayed using a -based
single-copy chromosomal lacZ operon fusion system. As
shown in Figure 2C, inactivation of PRnaG causes a
 3.5-fold increase of the expression of the ULS1129
fusion as compared to that of the wt construct
ULS1127, thus conﬁrming that RnaG transcription nega-
tively interferes with PicsA transcription. On the other
hand inactivation of PicsA gives rise only to a slightly
enhanced b-gal level from PRnaG (compare ULS1288 and
ULS1287). By measuring the levels of b-gal expression of
ULS1288 and ULS1129 fusions, which do not account for
TI eﬀects, it appears evident that PRnaG is endowed with
 3-fold stronger transcriptional activity than PicsA.
Altogether, these results clearly indicate that TI contrib-
utes to the coordinate regulation of this genetic system.
RnaG downregulates icsA by transcription attenuation
To investigate on the possible eﬀect of RnaG on icsA
transcription, we cloned the DNA sequence coding for
this antisense RNA into pTZ19R. The recombinant
plasmid (pTZRnaG) was used to synthesize RnaG by
in vitro run-oﬀ transcription with T7 RNA polymerase.
After puriﬁcation, RnaG was added to an in vitro tran-
scription assay programmed with a 331-bp DNA fragment
carrying the icsA promoter and an impaired PRnaG.A s
seen in Figure 3A, the band representing the full-length
run-oﬀ transcript of icsA (F) suddenly disappears even in
the presence of low amounts of RnaG (200fmol).
Concomitantly, a shorter product of  100nt (T) is
formed and its level progressively increases, becoming
the only transcript detectable at higher RnaG concentra-
tions. This result suggests that the antisense RNA may
promote transcription termination of the target gene by
a transcriptional attenuation mechanism. Such hypothesis
is strengthened by the lack of the truncated RNA molecule
(T) when the icsA81/4 mRNA, carrying mutations in the
potential intrinsic terminator (see below), is transcribed
(Figure 3B). Under the same experimental conditions,
the promoter activity of a control gene (hns) is not
aﬀected by RnaG (Figure 3C).
The role played by RnaG in the modulation of icsA
transcription has been further investigated in vivo by
introducing extra copies of RnaG into ULS1129, a R45
mono lysogen strain carrying a PicsA–lacZ fusion with an
inactivated RnaG promoter (Figure 2B). As shown in
Figure 4A, synthesis of RnaG from pGT1127 or
pGT1083 plasmids impairs the full expression of the chro-
mosomal PicsA, giving rise to a  3-fold reduction of b-gal
level, thus conﬁrming that, when provided in trans, RnaG
is able to inhibit icsA transcription. This result depends on
the presence of the RnaG molecule, since no repression is
observed transforming the cells with the pGT1129 which
carries a silenced PRnaG. By means of a real-time quanti-
tative PCR assay (QPCR), we also compared the level of
icsA mRNA in S. ﬂexneri M90T strain carrying either
pGT1083 or the pGEMT cloning vector. The presence
of RnaG encoding plasmid (pGT1083) gives rise to a
40% reduction of icsA mRNA (data not shown) in agree-
ment with the result obtained in ULS1129 background.
Moreover, to support the control eﬀect of RnaG on
icsA transcription, we decided to monitor the relative
expression of icsA and RnaG in S. ﬂexneri M90T strain
throughout the growth curve by a QPCR assay. As shown
in Figure 4B, during the exponential growth, RnaG
expression remains fairly constant, while icsA expression
shows a progressive increase. Interestingly, approaching
the stationary phase (OD600nm =1) RnaG expression
Figure 2. Transcriptional Interference regulates icsA and RnaG promoter activity. (A) About 200 ng of supercoiled plasmids pGT1127 (PicsA/RnaG),
pGT1129 (PicsA/RnaGmut) and pGT1083 (PicsAmut/RnaG), schematically represented in Figure 1C, were used as templates in in vitro transcription assays
carried out at 30 and 37 C. RnaG and icsA transcripts were detected by primer extension using a mixture of oligos G+50 and G+110. Lanes
marked G and C are the dideoxy sequencing reactions performed on pGT1127 with the oligo G+110 as primer. (B) Schematic organization of the E.
coli chromosome (strain P90C) carrying the diﬀerent ULS lacZ fusions. (C) b-Galactosidase activity of ULS transcriptional fusions was determined
on strains grown in LB broth (A600=0.4) at 37 C. Values represent the average of four independent experiments and the standard deviation is
indicated.
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decrease of icsA expression, thus supporting the hypothe-
sis that RnaG hampers the full expression of icsA gene.
Convergent transcription from face-to-face promoters,
as in the case of this genetic system, produces two tran-
scripts that partially basepair, possibly originating a RNA
duplex. The potential interaction between icsA and RnaG
transcripts was monitored by primer extension analysis
performed, in the presence or in the absence of puriﬁed
RnaG, on bulk RNA extracted from an E. coli HMG11
strain harboring the pGT1129, which synthesizes only the
icsA mRNA. We ﬁnd that, in the absence of RnaG, the 50
terminus matches with the previously identiﬁed
transcriptional start point of icsA (34). By contrast,
upon adding RnaG, the canonical start point of icsA is
apparently moved from position +1 to position +108
(Figure 5A). Assuming that the 50 leader region of the
icsA mRNA interacting with the RnaG yields a peculiar
secondary structure, which prevents the elongation of the
cDNA by the enzyme reverse transcriptase, we
investigated on the secondary structure of the icsA tran-
script by RNA probing. Initially, the puriﬁed 50 terminus
( 370nt) of the icsA mRNA was treated with the two
single-strand speciﬁc reagents dimethyl sulfate (DMS
modiﬁes unpaired adenines and cytosines) and
1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide
metho-p-toluene sulfonate (CMCT modiﬁes unpaired
uridines and guanines) (42). Data obtained by chemical
probing (Figure 5B) were superimposed on a computer
prediction generated by the MFOLD program (43). A
model of the structural organization of the ﬁrst 145nt of
free icsA mRNA is presented in Figure 5E. This RNA,
particularly its 50-end, forms a pronounced secondary
structure which is composed of a very long hairpin motif
(AH1) and a second helix containing both an apical and
an internal loop (AH2). Conversely, the 30-end of the icsA
Figure 3. The RnaG downregulates icsA transcription. Transcription
was investigated in vitro as function of increasing amounts of puriﬁed
RnaG using as template a 331-bp DNA fragment (from position –117
to +214), corresponding to the wt icsA promoter (A), the same DNA
fragment carrying the mutation 81/4 (see text and Figure 7A) (B) and a
480-bp DNA fragment (from position –314 to +166) corresponding to
the E. coli hns gene as control (57) (C). The wt and mutated icsA DNA
fragments were generated by PCR ampliﬁcation using the primer pair
G-100/ACC9 and plasmids pGT1129 and pGT1129M as templates,
respectively. F and T indicate full-length run-oﬀ and terminated icsA
transcripts, respectively. Transcripts were labeled by incorporating
[a
 32P]-UTP and lanes marked with M are diﬀerent RNA ladders.
Figure 4. RnaG negatively aﬀects icsA expression. (A) Expression
of icsA-lacZ fusion USL1129 was monitored in cells transformed
with pGT1083, pGT1127, pGT1129 or pGEMT vectors. (B) The
in vivo level of icsA and RnaG transcripts was monitored during
the growth of Shigella by real-time PCR. The expression trend
of either template, normalized to the corresponding maximum
(100%), is shown.
3368 Nucleic Acids Research, 2010,Vol.38, No. 10Figure 5. RNA probing of the icsA mRNA leader region either alone or in combination with RnaG. (A) Total RNA (15mg) was primer-extended in
the absence or in the presence of the indicated amounts of puriﬁed RnaG using the oligo ACC9. (B) In vitro transcribed icsA RNA (2 pmol) was
treated with increasing amounts of DMS (lanes 1, 0%; lane 2, 0.3%; lanes 3, 0.6%; lane 4, 1.2%) and CMCT (lanes 5, 0mg/ml; lane 6, 0.25mg/ml;
lane 7, 0.5mg/ml; lane 8, 1.0mg/ml). (C) The icsA mRNA (2 pmol) was treated with CMCT (3mg/ml) either without (lanes 1 and 2) or with diﬀerent
amounts of RnaG: 1 pmol (lanes 3 and 4), 2 pmol (lanes 5 and 6) and 4 pmol (lanes 7 and 8). Relatively to both (B) and (C), modiﬁed nucleotides
were detected by primer extension using the oligo G+187 and accessible sites were evaluated comparing samples incubated in the absence (–) and in
the presence of either DMS or CMCT. Lanes C, T, A and G correspond to DNA sequencing ladders made with the same primer. (D) About
300fmol of [
32P]-end-labeled icsA mRNA were digested with RNases T1 (2.5 10
–2 U, lanes 2, 7 and 12; 5 10
–2 U, lanes 3, 8 and 13) or T2
(1.1 10
–3 U, lanes 4, 9 and 14; 2.2 10
–3 U, lanes 5, 10 and 15) in the absence (lanes 1–5) and in the presence of 290 (lanes 6–10) and 580fmol
(lanes 11–15) of RnaG as indicated. M1 and M2 represent the OH– and T1 ladders, respectively. (E) Schematic representation of the secondary
structure of icsA mRNA (nucleotides from +1 to +145). The AH1 and AH2 motifs, nucleotides reactive to DMS or CMCT (circles), cleavage
points by T1 and T2 RNases (triangles), the initiation triplet and the S.D. sequence are indicated.
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chemical modiﬁcation, indicating that this region of the
molecule is single stranded. Next, we probed the structure
of the icsA mRNA together with the RnaG. As seen in
Figure 5C and Supplementary Figure S3, in the presence
of RnaG, an extended region ( 80nt) of the 50 terminus of
the icsA mRNA is no longer exposed to CMCT and DMS
modiﬁcation, particularly the unpaired nucleotides
forming the apical loop (U31–U34, A28), the uridine 24
and the adenine 51 of AH1. This strongly suggests that an
RnaG–icsA mRNA duplex is formed. Diﬀerently, the
non-folded intervening sequence (A68, C70, U72)
between AH1 and AH2, the apical loop (A86–A91) and
the bulged structure of AH2 (U77–A79 and A96–U102)
remain still accessible to the modifying agents even adding
a 2-fold excess of RnaG (Figures 5C and S3, lanes 7 and
8), indicating that nucleotides 80–120, although comple-
mentary to RnaG, are less important for RNA pairing.
The icsA mRNA structure obtained by chemicals was con-
ﬁrmed by enzymatic RNA probing with T1 and T2
ribonucleases (Figure 5D). This technique was also used
to analyzed the structure of icsA mRNA in the presence of
the RnaG. Depending on the amount of RnaG added,
cleavages produced by these two single-stranded RNA
speciﬁc enzymes at level of motifs AH1 (G30–G36, U50)
and AH2 (U79, A86–A89), on icsA transcript, are clearly
reduced or even hardly detectable, while no diﬀerence is
observed with or without RnaG downstream U111. RNA
probing experiments combined with MFOLD predictions
and the in vitro synthesis of a incompletely extended icsA
mRNA (Figure 3A) suggest that the progressive
complementation between the nascent transcript and the
RnaG hinders proper folding of helices AH1 and AH2 (at
least in part), thereby inducing structural changes in the
leader region of sense RNA. Such an alternative organi-
zation of the icsA mRNA has the potential to form a
stem–loop structure, characteristic of a Rho-independent
terminator (Figure 7A), which is likely responsible to
promote premature termination of the nascent icsA tran-
script by an antisense RNA-mediated transcriptional
attenuation mechanism (44). The proposed model is
shown in Figure 6.
To verify the validity of our model, we mutagenized
the pGT1129 creating the pGT1129M plasmid which
carries a four-base substitution at positions 81–84 on
icsA and encodes the mutated icsA81/4 mRNA
(Figure 7A). This mutation was designed to destabilize
the stem structure of the intrinsic terminator possibly
formed, during the icsA mRNA tramscription, upon inter-
action with the antisense RnaG. As previously shown in
Figure 3B, transcription of the icsA81/4 mRNA was not
able to originate the truncated product in the presence of
RnaG. Thus, we further analyzed the eﬀect of this
mutation by means of a technically diﬀerent in vitro
transcription assay programmed with supercoiled
plasmid DNA. The icsA transcript was monitored
by primer extension using a [
32P]-labeled oligo recognizing
only untruncated transcripts. Since we found that
the binding of RnaG to icsA mRNA can interfere with
elongation by reverse transcritpase (Figure 5A), RnaG
was added either at beginning (B) or at the end (E) of
the in vitro transcription reaction. We devised this
protocol to properly discriminate the negative eﬀects,
caused by RnaG, on transcription from those on the fol-
lowing elongation step. Therefore, this procedure has an
internal control. As seen in Figure 7B, RnaG mostly
represses transcription of the wt icsA (lanes B) without
signiﬁcantly aﬀecting the primer extension detection
(lanes E). Transcription inhibition is also observed using
a shorter form of RnaG, named RnaG120, containing
only the ﬁrst 120nt, suggesting that the antisense region
plays a key role in controlling icsA synthesis
(Supplementary Figure S2). The study of deletion
mutants of RnaG is actually in progress. On the
contrary, under the same experimental conditions, RnaG
is not able to cause transcription termination (except at
the highest amount tested), when the mutated icsA81/4
mRNA is synthesized (Figure 7C). The diﬀerent
response of icsA and icsA81/4 mRNAs to the
RnaG-mediated control is clearly evidenced when tran-
scription is expressed as the ratio B/E (Figure 7D).
These results strengthen the proposed model based on
transcriptional attenuation mechanism. Moreover, we
analyzed the secondary structure of RnaG and actually
the antisense region (nucleotides 1–120) has been
elucidated. As seen in Figure 8, the 50-end of RnaG is
characterized by three stem–loop motifs indicated as
GH1–GH3 that might play a role in the initial pairing
with the icsA mRNA.
Figure 6. Model showing the RnaG-mediated transcriptional attenua-
tion mechanism. (A) The interactions of GH3 and GH2 with AH1
possibly provide the initial nucleation points leading to duplex forma-
tion between RnaG and icsA mRNA. The GH1 hairpin is not repre-
sented contacting AH2 because at this stage the latter motif is not
completely transcribed. (B) RNA–RNA pairing causes modiﬁcations
of the secondary structure of the icsA mRNA resulting in the formation
of a potential intrinsic terminator between nucleotides +78 and +105
(see also Figures 7A and 8).
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During the past decade, small non-coding RNAs have
been discovered in all organisms. A major role of these
ncRNAs, acting by basepairing to their target mRNAs, is
primarily to regulate translation and messengers stability
(3,6). In bacteria, antisense RNA were ﬁrst detected on
extrachromosomal elements as plasmids, transposons
and bacteriophages (45); however, now it is becoming
increasingly clear that most of the chromosomally
encoded small RNAs (sRNAs) are part of regulatory
circuits required for fast adaptive response to stress and
environmental changes (46). The invasion of a host by a
pathogenic microorganism, which results in
reprogramming of the transcriptional activity, implies a
prompt adaptation to new growth conditions related to
the transition from a free living to a host-associated
state. In this context, 19 novel island-encoded sRNAs
have been recently identiﬁed in Salmonella and several
of these genes are expressed under stress conditions
when bacteria reside within macrophages (13). Thus,
RNA–RNA interactions appear decisive for virulence.
In the present study, we have identiﬁed a novel gene
encoding an antisense RNA (RnaG), located within the
icsA sequence of the S. ﬂexneri virulence plasmid (pINV).
The icsA gene (also known as virG) encodes a structural
protein involved in the reorganization of the cytoskeleton
upon penetration of bacteria into host cells and its activity
is crucial for the intra- and inter-cellular spreading of the
bacterial pathogen (20). After mapping the 50- and 30- ends
of RnaG, we focused on its ability to regulate the expres-
sion of icsA. Recent studies have shown that many
sRNAs, acting as antisense RNA, modulate the synthesis
of outer membrane proteins, thereby controlling the
surface composition of Gram-negative bacteria
(12,47,48). IcsA is indeed an outer membrane protein
and RnaG represents a novel example of this type of reg-
ulation. As opposed to other sRNAs and speciﬁcally to
those which control membrane proteins expression, aﬀect-
ing mostly the ability of target mRNAs to be translated,
we found that the RnaG is capable to downregulate icsA
transcription through dual not mutually exclusive
mechanisms.
We have shown that icsA and RnaG promoters are sub-
jected to TI regulation. TI provides an additional platform
for gene regulation and it has been described in phages,
transposable elements, plasmids, bacteria, yeast but less
frequently in higher eukaryotes. The main mechanisms,
by which TI can occur, are: (i) occlusion in which the
passage of elongating RNA polymerases (RNAPs)
blocks the access to the promoter; (ii) collisions between
elongating RNAPs, moving in opposite directions, leading
the premature termination of transcription; and (iii)
‘sitting duck’ interference which refers to the removal of
promoter-bound complexes by the passage of RNAP from
the opposing promoter (29). We have found that the
activity of PicsA is signiﬁcantly reduced when a transcrip-
tion process starts from the convergent PRnaG, indicating
that this phenomenon plays a key role in the regulation of
icsA (Figure 2). The extent of TI is higher in vitro
( 12-fold) than in vivo ( 3–4-fold), suggesting that
other factors (i.e. regulatory proteins), and, not simply
the promoter strength, could contribute to the regulation
of this genetic system into bacterial cells. Indeed, E. coli
strains used in this assay express the chromosomal protein
H-NS acting as icsA repressor, but not its natural
activator VirF (see below) carried by the large pINV vir-
ulence plasmid. At present, our results do not allow us to
ﬁgure out which type of the three aforementioned mech-
anisms is likely to be the major contributor to the overall
TI and this will be the aim of further investigations. To
our knowledge, we believe that RnaG is the ﬁrst example
of a non-coding RNA, which negatively aﬀects transcrip-
tion of the target gene by TI mechanism.
Figure 7. The mutation icsA81/4 abolishes the RnaG-mediated
transcriptional termination. (A) The hairpin followed by a polyU
sequence typical of Rho-independent transcription terminators and
base exchanges to create the icsA81/4 mutated mRNA are shown.
The underlined nucleotides represent the putative 30 terminus (positions
+104 and +105) of the abortive icsA mRNA predicted according to
the TransTerm algorithm (58). In vitro transcription was carried out at
37 C on 300ng of supercoiled plasmid DNA using pGT1129 (B) and
pGT1129M (C) as templates. The icsA and icsA81/4 mRNAs were
detected by primer extension using the oligo G+110 (from position
+97 to +116). Lanes G and A represent the sequencing reactions
using the same primer. After imager quantization, the radioactivity
associated with mRNA in (B) and (C) was used to calculate the ratio
B/E at the same RnaG concentration. These values have been plotted
as percentage (D) assuming 100% transcription in the absence of
RnaG.
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direct repression of icsA transcription acting primarily as
antisense RNA by targeting the icsA messenger. Such a
negative eﬀect on icsA promoter activity is observed both
in S. ﬂexneri and in E. coli and when the RnaG is provided
in trans. In particular, the analysis of the expression trend
of RnaG during the growth of S. ﬂexneri reveals that a
marked RnaG increase toward the onset of the stationary
phase is followed by a rapid reduction of the icsA tran-
script (Figure 4). In vitro transcription assays programmed
with a linear DNA fragment containing PicsA display,
solely in the presence of the RnaG, the appearance of an
abortive product of  100nt in place of the full-length
transcript. The truncated molecule is not formed when
the mutation 81/4, abolishing the function of the
transcriptional terminator, is introduced in the icsA
mRNA (Figure 3). Additionally, transcription termination
mediated by RnaG is observed also when a supercoiled
plasmid, carrying icsA, is used as template. In fact, the
shortened icsA mRNA can not be primer-extended with
the G+110 oligo, which fails to pair with its target
sequence on icsA mRNA, resulting in the reduction and/
or disappearance of the signal as function of RnaG con-
centration (Figure 7). Although, RnaG binds and exerts
its inhibitory eﬀect apparently without helper proteins,
Hfq and/or other chaperonins (49) might inﬂuence the
in vivo RnaG-dependent regulation of icsA. The inhibition
of PicsA is highly speciﬁc since it is completely abolished in
cells not expressing RnaG due to inactivation of promoter
and transcription of the control gene hns is not aﬀected
in vitro even by adding RnaG at elevated concentrations.
Combining computational predictions and data from
chemical and enzymatic RNA probing (Figures 5 and
S3), we have demonstrated that binding of RnaG to
the target icsA mRNA alters the secondary structure of
the untranslated region of the sense RNA. Not all of the
antisense region (120nt) of RnaG seems required to elicit
this structural change. Particularly, nucleotides down-
stream position 80 on icsA mRNA display a signiﬁcant
high reactivity to modifying agents even in the presence
of the antisense RNA, indicating that the ﬁrst 40nt of
RnaG are not stably interacting with icsA transcript.
Indeed, we propose that as the formation of the RNA–
RNA hybrid proceeds ( 80nt), the hairpins AH1 and
AH2 (in part) are not properly folded and the icsA
mRNA adopts a diﬀerent conformation. This alternate
structure, which originates in the course of the transcrip-
tion process but only in the presence of RnaG, gives rise to
an intrinsic terminator in the nascent messenger that likely
leads to premature termination of icsA synthesis
(Figure 6). The location of the terminator (between
position +78 and +105) is fully consistent with the size
of the truncated transcript ( 100nt) deduced from in vitro
transcription assays and with the RnaG-mediated shorten-
ing of cDNA in the primer extension experiment. The
proposed model is also strengthened by the considerably
reduced capability of RnaG to stop transcription and to
generate an abortive product with the icsA81/4 mutant,
which is impaired in forming the stem structure character-
istic of functional intrinsic terminators (Figures 3 and 7). It
is remarkable that RNA probing experiments provide a
static picture of ﬁnal structure of the icsA–RnaG
complex, generated by two molecules which are already
synthesized, denatured and refolded together, conditions
that facilitate their annealing through the entire comple-
mentary region. Moreover, little diﬀerences are obviously
observed depending on the nature of agents used (chemi-
cals or enzymes). For these reasons, in vitro transcription
experiments represent the assay that closer mimics the in
vivoconditionbecausesense–antisensepairinglikelyoccurs
during icsA mRNA elongation and folding.
Recently, we also started to investigate on the second-
ary structure of free RnaG and so far the ﬁrst 120nt have
been analyzed (Figure 8). Complete clariﬁcation of its
structure is actually in progress. Inspection of the struc-
tural conformation of sense and antisense RNAs reveals
that the unpaired bases of the apical loop (nucleotides
29–37) and of the basal bulge (nucleotides 57–61) of
AH1 might basepair with loops GH3 (nucleotides 84–92)
and GH2 (nucleotides 60–64), respectively. Analogously,
the apical (nucleotides 85–91) and internal loops
(nucleotides 98–102) of AH2 are complementary to
single-stranded regions found in the topologically similar
motif GH1 (nucleotides 30–36 and 18–22) of RnaG
(Figures 5E and 8B). Possibly, these interactions provide
the initial contact (kissing complex), which is followed by
rapid helix progression leading to RNA–RNA hybrid for-
mation. To date, this binding pathway was restricted to
plasmid replication as in R1 and in ColE1 and to the
regulation of insertion sequence IS10 (50). Transcription
attenuation mechanism was ﬁrst discovered many years
ago in the replication control of the staphylococcal
plasmid pT181 and of the streptococcal plasmids pIP501
and pAMb1 (6,44). More recently, attenuation has been
hypothesized also in the regulation of repABC genes
involved in the replication of tumor-inducing plasmids
of Agrobacterium tumefaciens (51), although the existence
of a terminator, upon RNA–RNA interaction, was only
predicted in silico. Thus, our study represents the ﬁrst
strong evidence of the occurrence of a transcription atten-
uation mechanism in genes from Gram-negative bacteria
and not restricted to plasmids replication. Regulation of
transcription by ncRNAs is certainly the less frequently
adopted mode of action even if it constitutes a very
powerful strategy to control the ﬁrst step of the ﬂow of
genetic information. In this context, a subset of small
RNAs associates directly with and regulates components
of the transcription machinery. The best-studied example
is the E. coli 6S RNA that inhibits transcription by
competing for DNA interaction with the RNA
polymerase (particularly with the 4.2 binding region of
s70), being recognized as a open promoter (52,53).
Other non-coding RNAs have been found in eukaryotic
cells targeting mostly the RNA polymerase (likely to the
6S RNA) and transcriptional factors (54).
RNA probing reveals that the AUG start codon and the
ribosome binding site of the icsA messenger, located
between positions +125 and +140, reside in a region
that remains single stranded and thus these sites are pre-
sumably available for ribosome recognition. Moreover,
the accessibility of this region to modifying agents and
RNases does not signiﬁcantly change also in the
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(Figure 5). Although further studies are needed to better
understand the complex regulation of icsA, these observa-
tions do not support the hypothesis that RnaG, in
addition to transcription, may also control the expression
of the target gene at post-transcriptional level.
Alternatively, we cannot exclude that the long duplex
between sense and antisense RNAs may represent a
target for RNase III resulting in RNA degradation
in vivo (6).
RnaG is one of largest regulatory sRNAs (450nt long)
so far identiﬁed and RNA probing of the 50-end and
in silico prediction show a high structured organization
consisting of several stem–loop motifs. Importantly, a
deleted form, RnaG120, containing only the antisense
region still preserves its ability to represses icsA transcrip-
tion in vitro (Supplementary Figure S3) as well as the
entire RnaG indicating that the ﬁrst 120nt possibly rep-
resent a functional domain. In light of its complexity,
RnaG, besides icsA, might be implicated in contacting
and modulating the expression of other virulence genes.
It is worth stressing that the 30-end of RnaG overlaps the
–35 promoter element of virA, an important virulence gene
responsible for destroying host cell microtubules (55) and
having its transcriptional start site reversely oriented
(position –364) with respect to that of icsA. Possibly, tran-
scription from RnaG promoter could aﬀect the activity of
the tandemly transcribed virA promoter interfering with
the binding of the RNA polymerase and/or of its speciﬁc
regulatory proteins through TI regulation mechanisms. In
this context, a well-characterized example of a multiple
target regulator is represented by RNAIII of S. aureus
which turns on/oﬀ the expression of genes involved in
pathogenesis in response to environmental and host
signals (56).
The expression of icsA is subjected to a complex regu-
latory network that besides being aﬀected by RnaG,
depends also on the coordinated action of two regulators,
VirF and H-NS (27,28). VirF is required to induce the
synthesis of the IcsA protein at the permissive temperature
of 37 C, a condition which the pathogen meets upon
invading the host. Preliminary experiments performed in
our laboratory show that VirF can stimulate the in vitro
activity of PicsA while repressing that of PRnaG
(unpublished data). Although several aspects of the regu-
lation of icsA mediated by VirF, H-NS and RnaG are
Figure 8. Secondary structure of the antisense region of RnaG. (A) Chemical probing of RnaG has been carried out essentially as described in
Figure 5B, using the oligo G+1H, in the presence of increasing amounts of DMS (lane 1, 0%; lane 2, 0.3%; lane 0.6%) and CMCT (lane 4, 0 mg/
ml; lane 5, 1.5 mg/ml; lane 6, 3 mg/ml; lane 7, 6 mg/ml). (B) Schematic representation of the secondary structure of RnaG (nucleotides from +1 to
+120). Numbering is according to 50 end of antisense RNA (position +120 on icsA sequence) and nucleotides reactive to DMS or CMCT in (A) are
circled in (B) except those between positions +97 and +108 that have been visualized in an additional experiment performed with an other primer
(data not shown). The same secondary structure was obtained using RnaG120 (data not shown).
Nucleic Acids Research, 2010,Vol.38, No. 10 3373currently under investigation, it is reasonable to hypothe-
size that VirF positively aﬀects icsA transcription both
directly and by relieving the inhibitory eﬀect caused by
RnaG.
In the past few years, predictive bioinformatics searches
have greatly facilitated the discovery of dozens of sRNAs
in diﬀerent species but identiﬁcation of direct targets and
understanding of their mechanistic aspects still lag behind.
Elucidating the mode of action of novel non-coding
sRNAs is obviously important, particularly in the light
of their role in response to the host environment and
during the infection process. This study contributes to
provide a cleaner picture of the biological functions of
antisense RNAs in human bacterial pathogens and
clariﬁes some relevant aspects of the complex regulation
of the invasion protein IcsA whose expression is critical
for construction of attenuated vaccinal strains.
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